| Literature DB >> 31993164 |
Fang Li1,2,3,4, Guangbin Huang5, Fang Tan6, Ruokun Yi1,2,3, Xianrong Zhou1,2,3, Jianfei Mu1,2,3, Xin Zhao1,2,3.
Abstract
Yogurt from Xinjiang, China, is a traditional Chinese fermented food rich in beneficial microorganisms, such as Lactobacillus plantarum KSFY06. In this study, the effect of KSFY06 on oxidative aging was investigated using live animal experiments. Molecular biological methods were used to analyze the serum and tissues of mice with oxidative aging induced by d-galactose, which showed that KSFY06 can inhibit the decline of heart, liver, spleen, and kidney caused by aging. The KSFY06 strain increased the activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), and glutathione (GSH) in serum and liver of aging mice, while the content of malondialdehyde (MDA) is reduced. Pathological observation showed that KSFY06 alleviated damage to the liver, spleen, and skin of oxidative aging mice. qPCR showed that, at high dose (2 × 109 cfu/kg per day), KSFY06 upregulates copper/zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), catalase (CAT) mRNA expression, and its downstream inducible nitric oxide synthase (iNOS) mRNA expression in liver and spleen tissues induced by d-gal. To a certain extent, these findings indicate that L. plantarum KSFY06 is able to protect against oxidative stress in the d-gal-induced aging model. In conclusion, L. plantarum KSFY06 may provide a potential research value in the prevention or alleviation of related diseases caused by oxidative stress.Entities:
Keywords: Lactobacillus plantarum KSFY06; aging; mice; oxidation
Year: 2019 PMID: 31993164 PMCID: PMC6977475 DOI: 10.1002/fsn3.1318
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Group of experiment animals
| Group | Treatment |
|---|---|
| Normal | Physiological saline (0.2 ml/10 g) |
| Control | Physiological saline (0.2 ml/10 g) + |
| LB | LB (2.0 × 109 cfu/kg, 0.2 ml/10 g) + |
| VitC | VitC (100 mg/kg, 0.2 ml/10 g) + |
| KSFY06‐H | KSFY06 (2.0 × 109 cfu/kg, 0.2 ml/10 g) + |
| KSFY06‐L | KSFY06 (2.0 × 108 cfu/kg, 0.2 ml/10 g) + |
Sequences of primers used in the qPCR assay
| Gene name | Sequence |
|---|---|
| eNOS | Forward: 5′‐TCAGCCATCACAGTGTTCCC‐3′ |
| Reverse: 5′‐ATAGCCCGCATAGCGTATCAG‐3′ | |
| nNOS | Forward: 5′‐ACGGCAAACTGCACAAAGC‐3′ |
| Reverse: 5′‐CGTTCTCTGAATACGGGTTGTTG‐3′ | |
| iNOS | Forward: 5′‐GTTCTCAGCCCAACAATACAAGA‐3′ |
| Reverse: 5′‐GTGGACGGGTCGATGTCAC‐3′ | |
| CAT | Forward: 5′‐GGAGGCGGGAACCCAATAG‐3′ |
| Reverse: 5′‐GTGTGCCATCTCGTCAGTGAA‐3′ | |
| SOD1 | Forward: 5′‐AACCAGTTGTGTTGTCAGGAC‐3′ |
| Reverse: 5′‐CCACCATGTTTCTTAGAGTGAGG‐3′ | |
| SOD2 | Forward: 5′‐CAGACCTGCCTTACGACTATGG‐3′ |
| Reverse: 5′‐CTCGGTGGCGTTGAGATTGTT‐3′ | |
| GAPDH | Forward: 5′‐AGGTCGGTGTGAACGGATTTG‐3′ |
| Reverse: 5′‐GGGGTCGTTGATGGCAACA‐3′ |
Organ index of mice in each group (n = 10)
| Group | Liver index (mg/g) | Spleen index (mg/g) | Kidney index (mg/g) | Heart index (mg/g) |
|---|---|---|---|---|
| Normal | 48.82 ± 0.16e | 3.37 ± 0.05c | 14.20 ± 0.04e | 5.58 ± 0.02b |
| Control | 39.14 ± 0.11a | 2.09 ± 0.02a | 10.32 ± 0.05a | 4.68 ± 0.01a |
| LB | 45.21 ± 0.12d | 4.04 ± 0.04d | 12.24 ± 0.06d | 6.08 ± 0.02c |
| VitC | 44.06 ± 0.06c | 2.97 ± 0.02b | 12.28 ± 0.04d | 5.30 ± 0.01b |
| KSFY06‐H | 45.76 ± 0.10d | 2.84 ± 0.01b | 12.22 ± 0.03c | 5.37 ± 0.03b |
| KSFY06‐L | 42.64 ± 0.03b | 2.25 ± 0.01a | 11.06 ± 0.02b | 5.17 ± 0.04b |
Data are means ± SD (n = 10/group). a–e In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day).
Activities of SOD, GSH, GSH‐Px, CAT, and MDA in serum of mice (n = 10)
| Group | SOD (U/ml) | GSH (mg/L) | GSH‐Px (U/ml) | CAT (U/ml) | MDA (nmol/ml) |
|---|---|---|---|---|---|
| Normal | 76.38 ± 0.56c | 3.55 ± 0.12c | 394.74 ± 23.12d | 4.72 ± 0.26e | 5.34 ± 0.95a |
| Control | 71.88 ± 0.38a | 1.71 ± 0.22a | 294.74 ± 15.21a | 2.89 ± 0.06a | 20.97 ± 0.81e |
| LB | 73.88 ± 0.72ab | 3.02 ± 0.31bc | 351.32 ± 10.09b | 3.12 ± 0.39b | 9.60 ± 1.64d |
| VitC | 74.35 ± 0.44ab | 2.81 ± 0.45b | 309.87 ± 20.78d | 3.29 ± 0.28c | 8.56 ± 0.22c |
| KSFY06‐H | 75.43 ± 0.61bc | 3.84 ± 0.27d | 369.47 ± 27.23e | 4.92 ± 0.19f | 5.44 ± 0.77ab |
| KSFY06‐L | 72.81 ± 0.31a | 2.96 ± 0.15b | 315.79 ± 30.45c | 3.51 ± 0.13d | 6.65 ± 1.20d |
Data are means ± SD (n = 10/group). a–e In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day).
Activities of SOD, GSH, GSH‐Px, CAT, and MDA in liver of mice (n = 10)
| Group | SOD (U/mg prot) | GSH (mg/g prot) | GSH‐Px (U/mg prot) | CAT (U/mg prot) | MDA (nmol/mg prot) |
|---|---|---|---|---|---|
| Normal | 245.42 ± 23.33d | 66.44 ± 11.07e | 1,129.11 ± 79.07e | 145.92 ± 12.22b | 77.13 ± 7.64d |
| Control | 169.45 ± 4.09b | 35.07 ± 4.01ab | 882.63 ± 80.02a | 102.50 ± 7.45e | 141.52 ± 16.88a |
| LB | 182.24 ± 15.75b | 33.12 ± 2.09a | 975.35 ± 94.35bc | 108.13 ± 17.74a | 60.40 ± 10.46ab |
| VitC | 242.40 ± 12.81cd | 46.16 ± 2.78cd | 1,070.42 ± 66.58d | 125.73 ± 4.83bc | 85.78 ± 7.27c |
| KSFY06‐H | 227.68 ± 22.27c | 50.63 ± 7.23d | 1,010.95 ± 96.03cd | 124.66 ± 19.24cd | 97.52 ± 7.78c |
| KSFY06‐L | 144.69 ± 19.30a | 39.72 ± 5.64bc | 902.45 ± 53.63ab | 115.07 ± 12.86d | 96.06 ± 12.19b |
Data are means ± SD (n = 10/group). a–e In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day).
Figure 1H&E pathological observation of liver in mice. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day)
Figure 2H&E pathological observation of spleen in mice. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day)
Figure 3H&E pathological observation of skin in mice. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day)
Figure 4mRNA expression level of SOD1, SOD2, CAT, eNOS, nNOS, and iNOS in liver tissue of mice. a–f In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day)
Figure 5mRNA expression level of SOD1, SOD2, CAT, eNOS, nNOS, and iNOS in spleen tissue of mice. a–e In the same column, different letters indicated significant differences between the two groups (p < .05), and the same letters indicated no significant difference between the two groups (p > .05) according to Duncan's multirange test. Normal = normal mice; Control = mice treated with d‐galactose injection (120 mg/kg per day); VitC = mice treated with d‐galactose and vitamin C (100 mg/kg per day); KSFY06 = mice treated with d‐galactose and increasing doses (L, H) of Lactobacillus plantarum KSFY06 (2 × 108, 2 × 109 cfu/kg per day); and LB = mice treated with d‐galactose and Lactobacillus delbrueckii subsp. bulgaricus (2 × 109 cfu/kg per day)